ENTITY
Haleon India

Haleon India (SKB IN)

34
Analysis
Consumer Staples • India
Haleon India, formerly GlaxoSmithKline Consumer Healthcare Ltd, is a leading fast-moving consumer healthcare company with a purpose to deliver better everyday health. The company's product portfolio spans oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands include Sensodyne, Eno, Iodex, Otrivin, Crocin, and Centrum. Haleon India was established in 1958 and is headquartered in Gurugram, India.
more
•03 Jul 2024 10:10

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Logo
2.7k Views
Share
bullish•Mankind Pharma
•25 Mar 2024 21:42

Mankind Pharma Placement - Well Flagged, past Deals Have Done Well but Its Expensive

ChrysCap is looking to raise around US$295m via selling a 2.8% stake in Mankind Pharma. In this note, we talk about the deal dynamics.

Logo
504 Views
Share
bullish•Mankind Pharma
•08 May 2023 12:45

Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag

Mankind Pharma  raised around US$527m in its upcoming India IPO. In this note, we talk about the demand updates and the trading dynamics.

Logo
601 Views
Share
bullish•Mankind Pharma
•19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
674 Views
Share
bearish•Honasa Consumer
•22 Feb 2023 10:10

Honasa Consumer Pre-IPO - The Negatives - Ad Spending Keeping Profits Low

Honasa Consumer (HC) is looking to raise about US$350m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Logo
587 Views
Share
x